Utility of selected neuroinflammatory markers following lethal traumatic brain injury: a combined biofluid and tissue-based assessment of TNF-α, CX3CL1, TNFR1, TNFR2 and CX3CR1 expression
- 23 April 2026
- journal article
- research article
- Published by Springer Nature in International journal of legal medicine
- Vol. 140 (5) , 1-12
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- TNF-α in traumatic brain injury: a bidirectional effect in regulating neuroimmune and inflammatory responsesCellular and Molecular Life Sciences, 2025
- Single intracerebroventricular TNFR2 agonist injection impacts remyelination in the cuprizone modelJournal of Molecular Medicine, 2025
- Elevated serum and cerebrospinal fluid levels of the synaptophysin and neurogranin with its altered brain expression in the early phase of traumatic brain injury as a potential marker of synaptic injuryInternational journal of legal medicine, 2025
- Forensic biomarkers of lethal traumatic brain injuryInternational journal of legal medicine, 2022
- Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic TargetsJournal of Molecular Neuroscience, 2021
- CX3CL1 Signaling in the Tumor Microenvironment2020
- Post-mortem cerebrospinal fluid diagnostics: cytology and immunocytochemistry method suitable for routine use to interpret pathological processes in the central nervous systemInternational journal of legal medicine, 2019
- Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine AgentsMolecular Neurobiology, 2016
- Fractalkine modulates TNF-? secretion and neurotoxicity induced by microglial activationGlia, 2000
- Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNSMolecular Brain Research, 1996